Our Signature Approach
What Sets Us Apart
As the market for biologic drugs grow, we are developing novel cost-saving, disruptive ideas that employ state-of-the-art innovations in bioprocessing to produce cheaper drug substances. Our target is to produce high purity NBE (New Biological Entities) as well as API (Active Pharmaceutical Ingredients) that have had regulatory approvals. What sets our platform technologies apart will be very much lower CAPEX (Capital Expenditure) and subsequently COG (Cost of Goods).
NO. 1 Protein Refolding
The main reason why many companies use mammalian cells instead of bacterial systems for the manufacture of recombinant proteins is due to the necessity of consistent protein refolding with retained bioactivity. We can achieve this is many models using E.coli systems that grow 20-25x faster than mammalian cell systems.
NO. 2 Future case studies of Chimera
Working towards treating age related macular degeneration, stopping solid tumours from being fed
Treating various viral diseases that could be the source of the next pandemic and to Reprogramme old cells into behaving like young ones again
NO. 3 A-Z chimeromic services available
We plan to offer front end-to back-end services to cut the chase in the brave new world of chimeromics or the science of the chimera. Imagine a new biologic being designed, tested and validated, have its production parameters optimized, be fully. lorem Ipsum
Collaborations to Develop Malaysia’s Drug Discovery ecosystem
In realizing IBX Protech’s vision, key collaborators has rise to the occasion to ensure the success of Malaysia’s drug discovery ecosystem. With pride, and a collaborative spirit. We will successfully birth to the next generation biologic drugs for treating cancer, infective diseases and treat neurodegeneration.


What are we up to?
Custom-made low-footprint movable bioreactors with environmentally friendly sterilization and low carbon footprints. Without revealing too much, we shall use novel nanotechnology systems to deliver biologic proteins with 90-95% purity with almost zero carry-over of bioprocess chemicals
Pipeline projects
In realizing IBX Protech’s vision, key collaborators has rise to the occasion to ensure the success of Malaysia’s drug discovery ecosystem. With pride, and a collaborative spirit. We will successfully birth to the next generation biologic drugs for treating cancer, infective diseases and treat neurodegeneration.
Interferon omega 6

Aliquam erat volutpat. Nullam bibendum arcu a quam hendrerit laoreet.
Collab with Genomic vaccine inst. To dev api etc

Phasellus euismod, leo in eleifend sollicitudin, metus justo cursus ex.
Zebrafish antiviral challenge model for VNN

Sed consequat enim vel nisi blandit, id auctor felis finibus.
Model to prove oral delivery live tilapia with TL(?)P

In hac habitasse platea dictumst.
Highly targeted RNA, polymeraize

Donec rhoncus.